NO952418L - Antipyretiske og analgetiske metoder og sammensetninger som inneholder optisk ren R-ketorolak - Google Patents

Antipyretiske og analgetiske metoder og sammensetninger som inneholder optisk ren R-ketorolak

Info

Publication number
NO952418L
NO952418L NO952418A NO952418A NO952418L NO 952418 L NO952418 L NO 952418L NO 952418 A NO952418 A NO 952418A NO 952418 A NO952418 A NO 952418A NO 952418 L NO952418 L NO 952418L
Authority
NO
Norway
Prior art keywords
ketorolac
pain
optically pure
antipyretic
compositions containing
Prior art date
Application number
NO952418A
Other languages
English (en)
Other versions
NO952418D0 (no
NO307546B1 (no
Inventor
Timothy J Barberich
Stephen L Matson
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO952418D0 publication Critical patent/NO952418D0/no
Publication of NO952418L publication Critical patent/NO952418L/no
Publication of NO307546B1 publication Critical patent/NO307546B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO952418A 1992-12-17 1995-06-16 Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav NO307546B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99198192A 1992-12-17 1992-12-17
PCT/US1993/012299 WO1994013283A1 (en) 1992-12-17 1993-12-17 Antipyretic and analgesic methods and compositions containing optically pure r-ketorolac

Publications (3)

Publication Number Publication Date
NO952418D0 NO952418D0 (no) 1995-06-16
NO952418L true NO952418L (no) 1995-08-03
NO307546B1 NO307546B1 (no) 2000-04-25

Family

ID=25537797

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952418A NO307546B1 (no) 1992-12-17 1995-06-16 Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav

Country Status (14)

Country Link
US (1) US5382591A (no)
EP (1) EP0674511B1 (no)
JP (1) JP2957701B2 (no)
KR (1) KR100264814B1 (no)
AT (1) ATE150969T1 (no)
AU (1) AU696620B2 (no)
CA (1) CA2151724C (no)
DE (1) DE69309492T2 (no)
DK (1) DK0674511T3 (no)
ES (1) ES2100046T3 (no)
FI (1) FI952985A (no)
GR (1) GR3023741T3 (no)
NO (1) NO307546B1 (no)
WO (1) WO1994013283A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
US5955504A (en) * 1995-03-13 1999-09-21 Loma Linda University Medical Center Colorectal chemoprotective composition and method of preventing colorectal cancer
US5981592A (en) * 1995-03-13 1999-11-09 Loma Linda University Medical Center Method and composition for treating cystic fibrosis
ES2253810T3 (es) * 1997-03-10 2006-06-01 Loma Linda University Medical Center Uso de r-aines para la prevencion de la enfermedad de alzheimer.
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6576191B1 (en) * 1999-09-30 2003-06-10 Therox, Inc. Apparatus for blood oxygenation
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US20030027867A1 (en) * 2001-06-29 2003-02-06 Myriad Genetics, Incorporated Use of R-NSAID compounds for anti-HIV treatment
AU2003211009A1 (en) * 2002-02-11 2003-09-04 Wake Forest University Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
DK1654002T4 (da) 2003-08-07 2014-02-17 Allergan Inc Sammensætninger til fremføring af terapeutiske midler til øjnene
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
US20050252144A1 (en) * 2004-04-29 2005-11-17 Macdonald Robert A Veneers for walls, retaining walls and the like
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
MX2008003230A (es) * 2008-03-07 2009-09-07 Senosiain S A De C V Lab Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
CN112094271B (zh) * 2019-06-18 2023-03-21 鲁南制药集团股份有限公司 一种酮咯酸晶型及其制备方法
CN110540542A (zh) * 2019-09-12 2019-12-06 南京海融制药有限公司 一种苯乙酸类化合物的钠盐、结晶形式及其制备方法
EP4110329A4 (en) * 2020-02-24 2024-04-10 Yinuoke Medicine Science Technology Company Ltd. COMPOSITIONS AND METHODS FOR TREATING CYTOKINE STORM AND CYTOKINE RELEASE SYNDROME
CN114276350B (zh) * 2020-09-28 2023-05-16 鲁南制药集团股份有限公司 一种酮咯酸与吩嗪共晶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
WO1987006266A1 (en) * 1986-04-16 1987-10-22 Wisconsin Alumni Research Foundation ENZYMATIC PROCESS FOR PREPARING OPTICALLY-ACTIVE 1,2-DIHYDRO-3H-PYRROLO[1,2a]PYRROLE-1-CARBOXYLIC ACID DERIVATIVES
ES2086536T3 (es) * 1990-03-16 1996-07-01 Procter & Gamble Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
JP3541849B2 (ja) * 1991-04-19 2004-07-14 久光製薬株式会社 消炎鎮痛貼付剤
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac

Also Published As

Publication number Publication date
WO1994013283A1 (en) 1994-06-23
CA2151724C (en) 2000-10-31
DE69309492T2 (de) 1997-07-10
NO952418D0 (no) 1995-06-16
EP0674511B1 (en) 1997-04-02
GR3023741T3 (en) 1997-09-30
US5382591A (en) 1995-01-17
KR100264814B1 (ko) 2000-09-01
ES2100046T3 (es) 1997-06-01
NO307546B1 (no) 2000-04-25
FI952985A0 (fi) 1995-06-16
ATE150969T1 (de) 1997-04-15
JP2957701B2 (ja) 1999-10-06
AU696620B2 (en) 1998-09-17
DE69309492D1 (de) 1997-05-07
FI952985A (fi) 1995-08-16
JPH08505133A (ja) 1996-06-04
EP0674511A1 (en) 1995-10-04
KR950703951A (ko) 1995-11-17
CA2151724A1 (en) 1994-06-23
DK0674511T3 (da) 1997-04-21
AU5872194A (en) 1994-07-04

Similar Documents

Publication Publication Date Title
NO952418D0 (no) Antipyretiske og analgetiske metoder og sammensetninger som inneholder optisk ren R-ketorolak
EP0727994A4 (en) ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE ETODOLIC ACID
RU94042899A (ru) Способ достижения болеутоляющего эффекта, способ лечения и профилактики гипертермии у человека, болеутоляющая и жаропонижающая композиции, содержащие оптически чистый r (-) кетопрофен
DK0719154T3 (da) Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel
NO960067L (no) Nytt farmasöytisk preparat
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
GEP20063720B (en) Triamide-Substituted Indoles, Benzofuranes and Benzothiophenes as Inhibitors of Microsomal Triglyceride Transfer Protein (MTP) and/or Apolipoprotein B (Apo B) Secretion
EP1022025A3 (en) Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron
NO973516D0 (no) Behandling av urininkontinens ved anvendelse av (S)-oksybutenin og (S)-desetyloksybutenin
HUP9904360A2 (hu) Eljárás emesis és központi idegrendszeri rendellenességek kezelésére, optikailag tiszta (+)-norciszaprid alkalmazásával
DK0771200T3 (da) Anvendelse af raloxifen og dets analoger til fremstilling af et medikament til behandling af virale sygdomme
DK0652000T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
DE68927519D1 (de) Behandlung von erhöhtem Blutdruck
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DK0769945T3 (da) Brug af 2-phenyl-3-aroylbenzothiophenderivater til fremstilling af et medikament til behandling af knogler og knoglebrud
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
MD1469G2 (ro) Metodă de tratament al şocului combustional
RU94027336A (ru) Способ профилактики послеоперационной иммунной недостаточности

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2002